BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 19395688)

  • 21. Sustained-release bupropion for smoking cessation in a Chinese sample: a double-blind, placebo-controlled, randomized trial.
    Sheng LX; Tang YL; Jiang ZN; Yao CH; Gao JY; Xu GZ; Tong XY
    Nicotine Tob Res; 2013 Feb; 15(2):320-5. PubMed ID: 22614545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bupropion sustained release and smoking cessation.
    Goldstein MG
    J Clin Psychiatry; 1998; 59 Suppl 4():66-72. PubMed ID: 9554323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
    J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year.
    Grassi MC; Enea D; Ferketich AK; Lu B; Nencini P
    Nicotine Tob Res; 2009 Sep; 11(9):1114-21. PubMed ID: 19654237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of bupropion for smoking cessation.
    Richmond R; Zwar N
    Drug Alcohol Rev; 2003 Jun; 22(2):203-20. PubMed ID: 12850907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
    Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J
    Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.
    Fossati R; Apolone G; Negri E; Compagnoni A; La Vecchia C; Mangano S; Clivio L; Garattini S;
    Arch Intern Med; 2007 Sep; 167(16):1791-7. PubMed ID: 17846399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Offering telephone counseling to smokers using pharmacotherapy.
    Boyle RG; Solberg LI; Asche SE; Boucher JL; Pronk NP; Jensen CJ
    Nicotine Tob Res; 2005 Apr; 7 Suppl 1():S19-27. PubMed ID: 16036266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trial of an intervention to facilitate recycling for relapsed smokers.
    Partin MR; An LC; Nelson DB; Nugent S; Snyder A; Fu SS; Willenbring ML; Joseph AM
    Am J Prev Med; 2006 Oct; 31(4):293-9. PubMed ID: 16979453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
    Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
    Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the efficacy of two Internet-based, computer-tailored smoking cessation programs: a randomized trial.
    Etter JF
    J Med Internet Res; 2005 Mar; 7(1):e2. PubMed ID: 15829474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking cessation interventions in clinical practice.
    Cornuz J
    Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):397-404. PubMed ID: 17681834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bupropion for smoking cessation in patients hospitalized with acute myocardial infarction: a randomized, placebo-controlled trial.
    Eisenberg MJ; Grandi SM; Gervais A; O'Loughlin J; Paradis G; Rinfret S; Sarrafzadegan N; Sharma S; Lauzon C; Yadav R; Pilote L;
    J Am Coll Cardiol; 2013 Feb; 61(5):524-32. PubMed ID: 23369417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.
    Cox LS; Patten CA; Niaura RS; Decker PA; Rigotti N; Sachs DP; Buist AS; Hurt RD
    J Gen Intern Med; 2004 Aug; 19(8):828-34. PubMed ID: 15242467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
    McCarthy DE; Piasecki TM; Lawrence DL; Jorenby DE; Shiffman S; Fiore MC; Baker TB
    Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
    Levin FR; Evans SM; Brooks DJ; Kalbag AS; Garawi F; Nunes EV
    Drug Alcohol Depend; 2006 Feb; 81(2):137-48. PubMed ID: 16102908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varenicline and bupropion sustained-release combination therapy for smoking cessation.
    Ebbert JO; Croghan IT; Sood A; Schroeder DR; Hays JT; Hurt RD
    Nicotine Tob Res; 2009 Mar; 11(3):234-9. PubMed ID: 19246427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No gender difference in effectiveness of smoking cessation treatment in a Brazilian real-life setting.
    Chatkin JM; Abreu CM; Blanco DC; Tonietto R; Scaglia N; Wagner MB; Fritscher CC
    Int J Tuberc Lung Dis; 2006 May; 10(5):499-503. PubMed ID: 16704030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.